Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 9/20 | 0.38 |
| ▸ | MAPK9 | P45984 | 8/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | CCNC | P24863 | 2/20 | 0.35 |
| ▸ | CDK8 | P49336 | 2/20 | 0.35 |
| ▸ | TDO2 | P48775 | 2/20 | 0.34 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12169057 | 0.99 | CYP17A1 (0.41) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12098148 | 0.96 | CYP17A1 (0.41) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12169070 | 0.96 | CYP11B1 (0.41) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12442771 | 0.95 | CYP17A1 (0.43) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL17366394 | 0.95 | CYP11B1 (0.39) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12169016 | 0.95 | CYP17A1 (0.42) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12168985 | 0.95 | CYP17A1 (0.42) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12169020 | 0.95 | CYP17A1 (0.42) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12098142 | 0.95 | CYP17A1 (0.42) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 | |
| SCHEMBL12169028 | 0.94 | CYP17A1 (0.44) | CYP17A1CYP19A1CYP11B1CYP11B2MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3244465-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2022-04-20 | — | — | EP | disclosed |
| EP-3223330-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2022-02-23 | — | — | EP | disclosed |
| US-11158811-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2021-10-26 | — | — | US | disclosed |
| US-10892420-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2021-01-12 | — | — | US | disclosed |
| US-10818844-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-10-27 | — | — | US | disclosed |
| US-10693078-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-06-23 | — | — | US | disclosed |
| US-10593884-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| EP-3133665-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2020-03-04 | — | — | EP | disclosed |
| US-10566540-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| EP-3266781-B1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2020-02-12 | — | — | EP | disclosed |
| US-8748014-B2 | Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8748014-B2 | Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8748014-B2 | Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| EP-2704225-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-20140021451-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20140021451-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| EP-2500346-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2012-09-19 | — | — | EP | disclosed |
| US-20120228598-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120228598-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120228598-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10593884-B2 | Organic electroluminescent device | AHR, SLC18A1, KCNH1 | CYP17A1 355/4885CYP19A1 42/4885CYP11B1 272/4885 |
| US-10693078-B2 | Organic electroluminescent device | KCNN2, SLC7A5, KCNH3 | CYP17A1 1626/4885CYP19A1 638/4885CYP11B1 2460/4885 |
| US-10818844-B2 | Organic electroluminescent device | AHR, ARNT, TRPV4 | CYP17A1 1258/4885CYP19A1 365/4885CYP11B1 480/4885 |
| US-10566540-B2 | Organic electroluminescent device | KCNN2, SLC7A5, KCNN1 | CYP17A1 1181/4885CYP19A1 527/4885CYP11B1 1702/4885 |
| US-10892420-B2 | Organic electroluminescent device | SLC7A5, KCNN2, SLC43A1 | CYP17A1 1630/4885CYP19A1 626/4885CYP11B1 2072/4885 |
| US-20120228598-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | PNPO, OXA1L, NLRP1 | CYP17A1 1511/4885CYP19A1 596/4885CYP11B1 654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.